Puma Biotechnology appoints Allison Dorval to board of directors

PUMA BIOTECHNOLOGY, INC.

Appointment effective July 15, 2021; term expires at 2022 annual meeting.
Dorval also appointed to the Audit Committee.
Currently CFO of Voyager Therapeutics (since Nov 2018); CPA with life sciences background.
Will receive standard non-employee director compensation and indemnification agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Allison Dorval

Director

PBYI · PUMA BIOTECHNOLOGY, INC.

Effective: 2021-07-15
Filed: July 14, 2021, 7:59 PM ET

On July 8, 2021, Allison Dorval, 45, was appointed to the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”), effective July 15, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Allison Dorval was appointed as Director at PUMA BIOTECHNOLOGY, INC..

Action: appointed
Role: Director

Exact text from the filing

On July 8, 2021, Allison Dorval, 45, was appointed to the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”), effective July 15, 2021.

View on SEC.gov

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001193125-21-215227

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.